Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | GAA | P10253 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | CA1 | P00915 | 6/20 | 0.45 |
| ▸ | CA2 | P00918 | 6/20 | 0.45 |
| ▸ | CA9 | Q16790 | 3/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6079588 | 0.94 | LMNA (0.49) | LMNAGAAALDH1A1L3MBTL1MEN1 | |
| SCHEMBL6079074 | 0.94 | LMNA (0.54) | LMNAGAAALDH1A1L3MBTL1MEN1 | |
| SCHEMBL6078876 | 0.91 | MEN1 (0.48) | ALDH1A1MEN1KMT2ACA1CA2 | |
| SCHEMBL6078568 | 0.85 | MEN1 (0.48) | ALDH1A1MEN1KMT2A | |
| SCHEMBL6079143 | 0.85 | ALDH1A1 (0.64) | LMNAGAAALDH1A1L3MBTL1MEN1 | |
| SCHEMBL6079442 | 0.85 | MEN1 (0.50) | ALDH1A1MEN1KMT2ACA1CA2 | |
| SCHEMBL6078719 | 0.84 | MEN1 (0.55) | ALDH1A1MEN1KMT2ACA1CA2 | |
| SCHEMBL6079922 | 0.83 | MAPT (0.60) | LMNAGAAALDH1A1L3MBTL1MEN1 | |
| SCHEMBL6078679 | 0.83 | LMNA (0.56) | LMNAGAAALDH1A1L3MBTL1MEN1 | |
| SCHEMBL6078415 | 0.81 | ALDH1A1 (0.59) | LMNAGAAALDH1A1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7071231-B2 | Naphthalene ureas as glucose uptake enhancers | TELIK, INC. (US) | 2006-07-04 | — | — | US | disclosed |
| US-6458998-B1 | NAPHTHALENEUREAS AS ANTIDIABETIC AGENTS | TELIK, INC. | 2002-10-01 | — | — | US | disclosed |